Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has informed the stock exchanges (BSE, Calcutta Stock Exchange, and MSEI) that the company does not have any unutilised funds as of 30th September 2025 from any past public issue, rights issue, preferential issue, or qualified institutional placement (QIP). Because there are no unutilised funds, no deviation or variation statement (Annexure-A) has been submitted. This is a routine quarterly compliance filing under SEBI's Listing Obligation and Disclosure Requirements Regulations, signed by Whole Time Director Aman Patel on 8 November 2025.
This is a neutral, compliance-related disclosure with no material impact on shareholders or the stock price — it simply confirms the company has no leftover issue proceeds to report on.